Page last updated: 2024-11-03

propofol and Fatty Liver

propofol has been researched along with Fatty Liver in 4 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research Excerpts

ExcerptRelevanceReference
"Propofol infusion syndrome (PRIS) is defined as acute bradycardia progressing to asystole combined with lipemic plasma, fatty liver enlargement, metabolic acidosis with negative base excess >10 mmol l(-1), rhabdomyolysis or myoglobinuria associated with propofol infusion."8.85Propofol infusion syndrome: update of clinical manifestation and pathophysiology. ( Bein, B; Fudickar, A, 2009)
"Propofol has been associated with severe adverse reactions in children receiving intensive care."6.40Lactic acidemia and bradyarrhythmia in a child sedated with propofol. ( Cox, PN; Cray, SH; Robinson, BH, 1998)
"Propofol is a widely used rapidly acting sedating or hypnotic agent in the intensive care setting."5.35Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. ( Ko, DY; Rison, RA, 2009)
"Propofol infusion syndrome (PRIS) is defined as acute bradycardia progressing to asystole combined with lipemic plasma, fatty liver enlargement, metabolic acidosis with negative base excess >10 mmol l(-1), rhabdomyolysis or myoglobinuria associated with propofol infusion."4.85Propofol infusion syndrome: update of clinical manifestation and pathophysiology. ( Bein, B; Fudickar, A, 2009)
"Propofol has been associated with severe adverse reactions in children receiving intensive care."2.40Lactic acidemia and bradyarrhythmia in a child sedated with propofol. ( Cox, PN; Cray, SH; Robinson, BH, 1998)
"Propofol is a widely used rapidly acting sedating or hypnotic agent in the intensive care setting."1.35Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. ( Ko, DY; Rison, RA, 2009)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rison, RA1
Ko, DY1
Fudickar, A1
Bein, B1
Devlin, JW1
Mallow-Corbett, S1
Riker, RR1
Cray, SH1
Robinson, BH1
Cox, PN1

Reviews

3 reviews available for propofol and Fatty Liver

ArticleYear
Propofol infusion syndrome: update of clinical manifestation and pathophysiology.
    Minerva anestesiologica, 2009, Volume: 75, Issue:5

    Topics: Acidosis; Acute Disease; Adult; Age Factors; Anesthetics, Intravenous; Animals; Bradycardia; Brain I

2009
Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit.
    Critical care medicine, 2010, Volume: 38, Issue:6 Suppl

    Topics: Acidosis; Analgesics; Antipsychotic Agents; Bradycardia; Cardiovascular Diseases; Critical Care; Dru

2010
Lactic acidemia and bradyarrhythmia in a child sedated with propofol.
    Critical care medicine, 1998, Volume: 26, Issue:12

    Topics: Acidosis, Lactic; Bradycardia; Conscious Sedation; Fatty Liver; Humans; Hyperlipidemias; Hypnotics a

1998

Other Studies

1 other study available for propofol and Fatty Liver

ArticleYear
Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus.
    Clinical neurology and neurosurgery, 2009, Volume: 111, Issue:6

    Topics: Adolescent; Anticonvulsants; Fatty Liver; Female; Humans; Midazolam; Propofol; Status Epilepticus; T

2009